The Evidence Based Rheumatology Podcast

The Evidence Based Rheumatology Podcast header image 1

E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis

August 15th, 2019

Finally got around to tackling the JAKi this week.  I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo.  I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum! 

Podbean App

Play this podcast on Podbean App